Cyclacel Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.44 | -$1.44 | -$1.44 |
| Q2 2024 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q3 2024 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q1 2025 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q2 2025 | 1 | -$0.30 | -$0.30 | -$0.30 |
| Q3 2025 | 1 | -$0.30 | -$0.30 | -$0.30 |
| Q4 2025 | 1 | -$0.30 | -$0.30 | -$0.30 |
Cyclacel Pharmaceuticals, Inc. Earnings Date And Information
Cyclacel Pharmaceuticals, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.72 earnings per share for the quarter, topping analysts' consensus estimates of $-0.83 by $0.11. The company had revenue of 10 for the quarter and had revenue of 420,000 for the year. Cyclacel Pharmaceuticals, Inc. has generated $-27 earnings per share over the last year ($-26.75 diluted earnings per share) and currently has a price-to-earnings ratio of -0.07. Cyclacel Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Cyclacel Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.00 | $10,000 | $10 | ||
| 08/14/2024 | Q2 2024 | -$0.83 | -$1.80 | -0.97 | $30,000 | $4,000 |
| 05/14/2024 | Q1 2024 | -$4.93 | -$2.27 | 2.66 | $29,000 | |
| 04/29/2024 | Q4 2023 | -$6.17 | $31,000 | |||
| 11/28/2023 | Q3 2023 | -$7.23 | $16,000 | |||
| 08/10/2023 | Q2 2023 | -$6.51 | $373,000 | |||
| 05/11/2023 | Q1 2023 | -$10.19 | -$6.94 | 3.25 | $0 | |
| 11/28/2023 | Q4 2022 | -$8.87 | $0 | |||
| 11/10/2022 | Q3 2022 | -$0.41 | $0 | |||
| 08/11/2022 | Q2 2022 | -$0.45 | $0 | |||
| 05/12/2022 | Q1 2022 | -$0.41 | $0 | |||
| 03/30/2022 | Q4 2021 | -$0.54 | $0 | |||
| 11/12/2021 | Q3 2021 | -$0.53 | $0 | |||
| 08/12/2021 | Q2 2021 | -$0.56 | $0 | |||
| 05/14/2021 | Q1 2021 | -$0.50 | $0 | |||
| 03/01/2021 | Q4 2020 | -$0.57 | $0 | |||
| 11/12/2020 | Q3 2020 | -$0.46 | $0 | |||
| 08/13/2020 | Q2 2020 | -$0.56 | $0 | |||
| 05/12/2020 | Q1 2020 | -$41.98 | -$1.42 | 40.56 | $0 | |
| 03/05/2020 | Q4 2019 | -$2.68 | $0 |
Cyclacel Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Cyclacel Pharmaceuticals, Inc.'s earnings date?
Cyclacel Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
-
Did Cyclacel Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Cyclacel Pharmaceuticals, Inc. (:CYCC) reported $-0.72 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.83 by $0.11.
-
How can I listen to Cyclacel Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Cyclacel Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Cyclacel Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Cyclacel Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Cyclacel Pharmaceuticals, Inc. generate each year?
Cyclacel Pharmaceuticals, Inc. (:CYCC) has a recorded annual revenue of $420,000.
-
How much profit does Cyclacel Pharmaceuticals, Inc. generate each year?
Cyclacel Pharmaceuticals, Inc. (:CYCC) has a recorded net income of $420,000. Cyclacel Pharmaceuticals, Inc. has generated $-26.75 earnings per share over the last four quarters.
-
What is Cyclacel Pharmaceuticals, Inc.'s price-to-earnings ratio?
Cyclacel Pharmaceuticals, Inc. (:CYCC) has a price-to-earnings ratio of -0.07 and price/earnings-to-growth ratio is -0.
